LPA suppresses HLA-DR expression in human melanoma cells: a potential immune escape mechanism involving LPAR1 and DR6-mediated release of IL-10.

Autor: Major E; Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.; HUN-REN-SU Cerebrovascular and Neurocognitive Disease Research Group, Budapest, Hungary., Lin KH; Department of Physiology, University of Tennessee Health Science Centre, Memphis, TN, USA.; Institute of Plant and Microbial Biology, Academia Sinica, Taipei, Taiwan, China., Lee SC; Department of Physiology, University of Tennessee Health Science Centre, Memphis, TN, USA., Káldi K; Department of Physiology, Semmelweis University, Budapest, Hungary., Győrffy B; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; Department of Biophysics, Medical School, University of Pecs, Pecs, Hungary.; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary., Tigyi GJ; Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Physiology, University of Tennessee Health Science Centre, Memphis, TN, USA., Benyó Z; Institute of Translational Medicine, Semmelweis University, Budapest, Hungary. benyo.zoltan@semmelweis.hu.; HUN-REN-SU Cerebrovascular and Neurocognitive Disease Research Group, Budapest, Hungary. benyo.zoltan@semmelweis.hu.

Publikováno v: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2024 Aug 26. Date of Electronic Publication: 2024 Aug 26.

Advancing prediction of age-related vascular cognitive impairment based on peripheral and retinal vascular health in a pilot study: a novel comprehensive assessment developed for a prospective workplace-based cohort (The Semmelweis Study).

Autor: Csipo T; Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary. csipo.tamas@semmelweis.hu.; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. csipo.tamas@semmelweis.hu.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. csipo.tamas@semmelweis.hu., Lipecz A; Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Mukli P; Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Péterfi A; Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Szarvas Z; Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Ungvari A; Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary., Alaoui LE; Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary., Sándor M; Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary., Kállai A; Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary., Fekete M; Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary., Fülöp GÁ; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Heart and Vascular Center, Semmelweis University, Budapest, Hungary., Tarantini S; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, USA.; Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; International Training Program in Geroscience, Doctoral College, Health Sciences Program/Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary., Csiszar A; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, USA.; Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; International Training Program in Geroscience, Doctoral College, Health Sciences Program/Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary., Benyó Z; Department of Translational Medicine, Semmelweis University, Budapest, Hungary.; Eötvös Loránd Research Network and Semmelweis University (ELKH-SE) Cerebrovascular and Neurocognitive Disorders Research Group, Budapest, H-1052, Hungary., Sótonyi P; Department of Vascular and Endovascular Surgery, Semmelweis University, Budapest, Hungary., Tabak AG; Institute of Preventive Medicine and Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.; UCL Brain Sciences, University College London, London, UK.; Department of Internal Medicine and Oncology, Semmelweis University, Faculty of Medicine, Budapest, Hungary., Merkely B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary., Yabluchanskiy A; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, USA.; Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; International Training Program in Geroscience, Doctoral College, Health Sciences Program/Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary., Ungvari Z; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, USA.; Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; International Training Program in Geroscience, Doctoral College, Health Sciences Program/Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.

Publikováno v: GeroScience [Geroscience] 2024 Nov 27. Date of Electronic Publication: 2024 Nov 27.

Ivermectin Synergizes with Modulated Electro-hyperthermia and Improves Its Anticancer Effects in a Triple-Negative Breast Cancer Mouse Model.

Autor: Aloss K; Institute of Translational Medicine, Semmelweis University, Üllői út 26., Budapest 1085, Hungary.; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest 1089, Hungary., Leroy Viana PH; Institute of Translational Medicine, Semmelweis University, Üllői út 26., Budapest 1085, Hungary., Bokhari SMZ; Institute of Translational Medicine, Semmelweis University, Üllői út 26., Budapest 1085, Hungary., Giunashvili N; Institute of Translational Medicine, Semmelweis University, Üllői út 26., Budapest 1085, Hungary., Schvarcz CA; Institute of Translational Medicine, Semmelweis University, Üllői út 26., Budapest 1085, Hungary.; HUN-REN-SU Cerebrovascular and Neurocognitive Diseases Research Group, Tűzoltó utca 37-47., Budapest 1094, Hungary., Bócsi D; Institute of Translational Medicine, Semmelweis University, Üllői út 26., Budapest 1085, Hungary., Koós Z; Institute of Translational Medicine, Semmelweis University, Üllői út 26., Budapest 1085, Hungary., Benyó Z; Institute of Translational Medicine, Semmelweis University, Üllői út 26., Budapest 1085, Hungary.; HUN-REN-SU Cerebrovascular and Neurocognitive Diseases Research Group, Tűzoltó utca 37-47., Budapest 1094, Hungary., Hamar P; Institute of Translational Medicine, Semmelweis University, Üllői út 26., Budapest 1085, Hungary.

Publikováno v: ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2024 Jul 17; Vol. 7 (8), pp. 2496-2506. Date of Electronic Publication: 2024 Jul 17 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction to: Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?

Autor: Tigyi G; Department of Physiology, University of Tennessee Health Science Center Memphis, 3 N. Dunlap Street, Memphis, TN, 38163, USA. gtigyi@uthsc.edu.; Department of Pathology, University of Tennessee Health Science Center Memphis, 3 N. Dunlap Street, Memphis, TN, 38163, USA. gtigyi@uthsc.edu., Dacheux MA; Department of Physiology, University of Tennessee Health Science Center Memphis, 3 N. Dunlap Street, Memphis, TN, 38163, USA., Lin KH; Department of Physiology, University of Tennessee Health Science Center Memphis, 3 N. Dunlap Street, Memphis, TN, 38163, USA., Yue J; Department of Pathology, University of Tennessee Health Science Center Memphis, 3 N. Dunlap Street, Memphis, TN, 38163, USA., Norman D; Department of Physiology, University of Tennessee Health Science Center Memphis, 3 N. Dunlap Street, Memphis, TN, 38163, USA., Benyó Z; Institute of Translational Medicine, Semmelweis University, POB 2, Budapest, H-1428, Hungary., Lee SC; Department of Physiology, University of Tennessee Health Science Center Memphis, 3 N. Dunlap Street, Memphis, TN, 38163, USA.

Publikováno v: Cancer metastasis reviews [Cancer Metastasis Rev] 2024 Jun; Vol. 43 (2), pp. 845.